NFKB1 and type 2 diabetes mellitus: This can help to clarify the mechanism of action of BHRS in alleviating IR in T2DM by regulating gut microbiota, improving intestinal mucosal permeability, and inhibiting the activation of TLR4/NF-κB signaling pathway.